BRIEF published on 10/05/2026 at 13:17, 2 hours 35 minutes ago ReproNovo Named Among "Fierce 15" Biotech Companies of 2026 Biotechnology Fertility Women's Health ReproNovo Fierce 15
PRESS RELEASE published on 10/05/2026 at 13:12, 2 hours 40 minutes ago FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026 ReproNovo named as one of 2026's Fierce 15 biotechnology companies by Fierce Biotech for innovative therapies targeting male and female infertility and women's health Innovation Biotechnology Fertility ReproNovo Fierce 15
BRIEF published on 07/06/2026 at 07:05, 2 months 30 days ago ReproNovo Begins EU Phase 2 Trial for Embryo Implantation Treatment ReproNovo RPN-002 Embryo Implantation NORDIC Trial Assisted Reproductive Technology
PRESS RELEASE published on 07/06/2026 at 07:00, 2 months 30 days ago ReproNovo Announces First Participant Dosed In EU Phase 2 Trial Of RPN-002 Embryo Implantation ReproNovo doses first participant in EU Phase 2 trial of RPN-002 for embryo implantation, aiming to increase IVF success rates with oxytocin receptor antagonist ReproNovo RPN-002 Embryo Implantation EU Phase 2 Trial IVF Success
BRIEF published on 03/20/2026 at 13:05, 6 months 16 days ago ReproNovo Appoints Mark Altmeyer as Chairman of the Board Biopharmaceutical Fertility Leadership ReproNovo Mark Altmeyer
PRESS RELEASE published on 03/20/2026 at 13:00, 6 months 16 days ago REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD ReproNovo appoints Mark Altmeyer as Chairman of the Board. Altmeyer brings 35+ years of biopharma leadership experience across multiple therapeutic areas Chairman Fertility Biopharma ReproNovo Mark Altmeyer
BRIEF published on 09/30/2025 at 07:05, 1 year ago ReproNovo Gains Approval for RPN-001 Clinical Trial in China Clinical Trial China Approval ReproNovo Reproductive Medicine RPN-001
PRESS RELEASE published on 09/30/2025 at 07:00, 1 year ago ReproNovo Announces Clinical Trial Approval Notice for RPN-001 in China ReproNovo receives approval for RPN-001 Phase 1 trial in China from NMPA, a key step in global development for male infertility treatment. Company expanding clinical programs in the U.S. and China China Male Infertility Clinical Trial ReproNovo RPN-001
BRIEF published on 07/01/2025 at 07:05, 1 year 3 months ago ReproNovo Initiates Phase 2 Trial for Male Infertility Drug in the U.S. Male Infertility Phase 2 Trial ReproNovo RPN-001 Low Testosterone
PRESS RELEASE published on 07/01/2025 at 07:00, 1 year 3 months ago REPRONOVO ANNOUNCES FIRST PARTICIPANT INCLUDED IN U.S. PHASE 2 TRIAL OF RPN-001 FOR MALE INFERTILITY ReproNovo announces first participant in U.S. Phase 2 trial of RPN-001 for male infertility, aiming to develop oral therapy for low testosterone men with impaired semen quality Male Infertility Phase 2 Trial ReproNovo RPN-001 Aromatase Inhibitor
Published on 10/05/2026 at 14:45, 1 hour 8 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 1 hour 23 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 1 hour 23 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 1 hour 53 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 1 hour 53 minutes ago GameSquare to Present at Upcoming Investor Conferences
Published on 10/05/2026 at 15:39, 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 10/05/2026 at 15:37, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 10/05/2026 at 15:00, 53 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 10/05/2026 at 11:15, 4 hours 37 minutes ago Statement of transactions in own shares from September 28, 2026 to October 2, 2026
Published on 10/05/2026 at 08:00, 7 hours 53 minutes ago BEYOND, Air Liquide accelerates lasting value creation with new strategic plan for 2030
Published on 10/05/2026 at 07:00, 8 hours 53 minutes ago Schneider Electric to acquire PTC, creating the next level of Energy and Industrial Intelligence
Published on 10/02/2026 at 17:45, 2 days 22 hours ago Information concerning the total number of voting rights and shares 2026 09 30
